|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Radioembolization of Symptomatic, Unresectable Neuroendocrine Hepatic Metastases Using Yttrium-90 Microspheres显示文摘 | Philipp M. Paprottka Ralf-T. Hoffmann Alexander Haug Wieland H. Sommer Franziska Rae?ler Christoph G. Trumm Gerwin P. Schmidt Nima Ashoori Maximilian F. Reiser Tobias F. Jakobs | 2012 | CardioVascular and Interventional Radiology2012，，2： | 2 |
| 2 | Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma<!-- Doctopic: CAN -->显示文摘 | Rita Golfieri Josè Ignacio Bilbao Livio Carpanese Roberto Cianni Daniele Gasparini Samer Ezziddin Philipp Marius Paprottka Francesco Fiore Alberta Cappelli Macarena Rodriguez Giuseppe Maria Ettorre Adelchi Saltarelli Onelio Geatti Hojjat Ahmadzadehfar Ale | 2013 | Journal of Hepatology2013，，： | 2 |
| 3 | Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma:factors associated with prolonged survival显示文摘 | Hoffmann RT Paprottka PM Schon A | 2012 | Cardiovasc Intervent Radiol2012，35，1： | 1 |
| 4 | Image fusion in the management of thermal tumor ablation of the liver显示文摘 | Clevert DA Paprottka PM Helck A | 2012 | Clin Hemorheol Microcirc2012，52，24： | 1 |
| 5 | Image fusion in themanagement of thermal tumor ablation of the liver 显示文摘 | Clevert DA* Paprottka PM Helck A | 2012 | ClinHemorheol Microcirc2012，52，24： | 1 |
| 6 | Transarterial he- patic yttrium-90 radioembolization in patients with unreseetable intrahepatic cholangiocarcinoma~ factors associated with pro- longed survival显示文摘 | Hoffmann RT Paprottka PM SchOn A | 2012 | Cardiovasc Intervent Radiol2012，35，1： | 1 |
| 7 | Arterial therapies of colorectal cancer metastases to the liver 显示文摘 | Hoffmann RT Paprottka P Jakobs TF | 2011 | Abdom Imaging2011，36，6： | 1 |
| 8 | High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy显示文摘BACKGROUND Liver transplantation(LT)presents a curative treatment option in patients with early stage hepatocellular carcinoma(HCC)who are not eligible for resection or ablation therapy.Due to a risk of up 30%for waitlist drop-out upon tumor progression,bridging therapies are used to halt tumor growth.Transarterial chemoembolization(TACE)and less commonly stereotactic body radiation therapy(SBRT)or a combination of TACE and SBRT,are used as bridging therapies in LT.However,it remains unclear if one of those treatment options is superior.The analysis of explant livers after transplantation provides the unique opportunity to investigate treatment response by histopathology.AIM To analyze histopathological response to a combination of TACE and SBRT in HCC in comparison to TACE or SBRT alone.METHODS In this multicenter retrospective study,27 patients who received liver transplantation for HCC were analyzed.Patients received either TACE or SBRT alone,or a combination of TACE and SBRT as bridging therapy to liver transplantation.Liver explants of all patients who received at least one TACE and/or SBRT were analyzed for the presence of residual vital tumor tissue by histopathology to assess differences in treatment response to bridging therapies.Statistical analysis was performed using Fisher-Freeman-Halton exact test,Kruskal-Wallis and Mann-Whitney-U tests.RESULTS Fourteen patients received TACE only,four patients SBRT only,and nine patients a combination therapy of TACE and SBRT.There were no significant differences between groups regarding age,sex,etiology of underlying liver disease or number and size of tumor lesions.Strikingly,analysis of liver explants revealed that almost all patients in the TACE and SBRT combination group(8/9,89%)showed no residual vital tumor tissue by histopathology,whereas TACE or SBRT alone resulted in significantly lower rates of complete histopathological response(0/14,0%and 1/4,25%,respectively,P value<0.001).CONCLUSION Our data suggests that a combination of TACE and SBRT increases the rate of complete histopathological response compared to TACE or SBRT alone in bridging to liver transplantation. | Ulrike Bauer Sabine Gerum Falk Roeder Stefan Münch Stephanie E Combs Alexander B Philipp Enrico N De Toni Martha M Kirstein Arndt Vogel Carolin Mogler Bernhard Haller Jens Neumann Rickmer F Braren Marcus R Makowski Philipp Paprottka Markus Guba Fabian Geisler Roland M Schmid Andreas Umgelter Ursula Ehmer | 2021 | World Journal of Gastroenterology2021，27，24： | 1 |
| 9 | Muhimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation 显示文摘 | Ashoori N Bamberg F Paprottka P | 2012 | Digestion2012，86，4： | 1 |
| 10 | Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival显示文摘 | Ralf-T. Hoffmann Philipp M. Paprottka Agnes Sch?n Fabian Bamberg Alexander Haug Eva-Maria Dürr Barbara Rauch Christoph T. Trumm Tobias F. Jakobs Thomas K. Helmberger Maximilian F. Reiser Frank T. Kolligs | 2012 | CardioVascular and Interventional Radiology2012，，1： | 1 |
| 11 | Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer显示文摘 | Wolfgang Peter Fendler Donfack Beauclair Philippe Tiega Harun Ilhan Philipp M. Paprottka Volker Heinemann Tobias F. Jakobs Peter Bartenstein Marcus Hacker Alexander Robert Haug | 2013 | Journal of Nuclear Medicine2013，，8： | 1 |
| 12 | Transarterial hepatic yttrium -90 radloembolization in patients with unresectable intra- hepatic cholangiocarcinoma: factors associated with prolonged sur- vival显示文摘 | Hoffmann RT Paprottka PM Sch~n A | 2012 | Cardiovasc Intervent Radiol2012，35，： | 1 |
| 13 | Visualization, imaging and new preclinical diagnostics in radiation oncology显示文摘 | Cyran CC Paprottka PM Eisenblitter M | 2014 | Radiat Oncol2014，9，： | 1 |
| 14 | Multimodality treatment with conventional transcatheter arterial chemoem, holization and radiofrequency ablation for unresectable hepatocellular carcinoma 显示文摘 | Ashoori N Paprottka P Trumm C | 2012 | Digestion2012，85，1： | 1 |
| 15 | Image fusion in the management of thermal tumor ablation of the liver显示文摘 | Clevert DA Paprottka PM Helck A | 2012 | Clin Hemorheol Microcirc2012，52，24： | 1 |
| 16 | Technical and clinical outcome of percutaneous CT fluoroscopy-guided screw placement inunstable injuries of the posterior pelvic ring显示文摘 | Strobl FF Haeussler SM Paprottka PM | 2014 | Skel- etal Radiol2014，43，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员